Introduction
============

The retinal pigment epithelium (RPE) is a single layer of pigmented epithelial cells that supports the function and development of photoreceptors \[[@r1]\]. RPE dysfunction leads to many retinal degenerative diseases, including age-related macular degeneration (AMD) \[[@r2]\] and retinitis pigmentosa (RP) \[[@r3],[@r4]\]. Regeneration \[[@r5]\] and transplantation \[[@r6],[@r7]\] of the RPE could lead to new treatments for these retinal diseases. The success of these therapeutic approaches will rely on our understanding of the genetic regulation of RPE differentiation and paracrine signaling to the retina. A major technical limitation in studying RPE signaling is the difficulty obtaining pure and intact RPE tissue from small developing embryos, which has precluded accurate expression profiling of the RPE during development. We previously addressed this issue by developing an approach for estimating the RPE gene expression profile in the zebrafish by comparing microdissected RPE-attached retinas and RPE-free retinas \[[@r8],[@r9]\]. Subsequently, expression profiling of developing chick \[[@r10]\] and human \[[@r11]\] RPE has been reported. Higdon and colleagues recently demonstrated that RPE-specific gene expression could be detected in purified pigment cells from whole zebrafish embryos, using density gradient centrifugation and fluorescence-activated cell sorting (FACS) based on the pigment granule density of the cells \[[@r12]\]. The availability of these data sets has substantially facilitated the study of RPE development and the identification of RPE paracrine signals to the retina.

Several paracrine signaling molecules are known to play a role in mediating the interactions between the RPE and the retina during development. For example, pigment epithelium-derived factor (PEDF) is a glycoprotein that has been shown to mediate normal photoreceptor development in the frog \[[@r13]\] and chicken \[[@r14]\]. Two additional signaling molecules, glial cell-derived neurotrophic factor (GDNF) and brain-derived neurotrophic factor (BDNF) are released by cultured human RPE cells, and their presence in culture medium enhances the survival of dopaminergic neurons \[[@r15]\]. Similar to PEDF, GDNF also regulates photoreceptor development in chickens \[[@r14],[@r16]\]. Another class of signaling molecules, Bone morphogenetic protein (Bmp), is also involved in the development of the retina and the RPE. For instance, Bmp4 and Bmp7 expressed in the surface ectoderm overlying the optic vesicle in the chick are essential and sufficient for RPE specification \[[@r17]\]. In addition, Bmp2 and Bmp4 in adult bovine RPE act as potential negative growth regulators and are downregulated during injury in the retina and the RPE \[[@r18]\]. Finally, the canonical wingless (Wnt) signal transduction pathway was recently implicated in RPE development and retinal degeneration. In particular, Wnt activity is essential for transcriptional activation of Mitf and Otx2, two genes that are crucial for RPE specification in mice \[[@r19],[@r20]\]. Interestingly, the conditional knockout of β-catenin in RPE not only affects RPE differentiation but also disrupts retinal morphogenesis and lamination. These findings suggest that Wnt likely mediates signaling interactions between the RPE and the retina.

Although the study of the signaling molecules described above has contributed to our understanding of the interactions between the RPE and the retina, it is clear that only a fraction of the vast genetic network that underlies RPE and retinal development has been described. The purpose of this study was to establish a genomic approach for identifying genes that control RPE differentiation and potential paracrine signals specifically secreted by the RPE. The model we used was a zebrafish SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily a, member 4 (*smarca4*; also known as *yng*) mutant \[[@r21]\]. This mutant has a null mutation in *smarca4,* and was originally described as a model with developmental problems in several organs, including the eye, ear, and heart \[[@r22]\]. *Smarca4* codes for the ATPase of the SWI/SNF chromatin remodeling complex, which is critical to regulation of gene expression during development. As a result of dysregulated gene expression, the retinal structure is disorganized, and appropriate retinal lamination is disrupted in the *smarca4* mutants. The retinal cells are specified but do not fully differentiate. We previously conducted an expression profiling experiment to identify candidate genes that underlie the retinal differentiation phenotype with microarray analysis \[[@r23]\]. The true discovery rate of the study was more than 90% and was highly concordant with the theoretical rate of 95% \[[@r24]\]. Subsequent functional characterizations of the candidate genes have also begun to reveal the gene network regulated by Smarca4 and its role in normal retinal differentiation \[[@r25]-[@r27]\].

In addition to the effect on retinal development, the *smarca4* mutation also plays a role in RPE differentiation. In fact, one of the earliest hallmarks used to identify *smarca4* was abnormal RPE pigmentation. We observed the integrity of the RPE layer and its adhesion to the retina were also compromised during our microdissection of *smarca4* retinas \[[@r23]\]. We hypothesized that these defects were caused by abnormal gene expression in *smarca4* RPE. In this study, we first characterized the defects in *smarca4* RPE differentiation with histological analysis. Then, we used our RPE expression analysis approach \[[@r8],[@r9]\] to obtain RPE gene expression in *smarca4*. To identify differential gene expression and potential paracrine signal transduction that might underlie the *smarca4* eye phenotype, an extension of our factorial microarray array analysis \[[@r23]\] was established. In particular, we used the fitted statistical models to build sequential rules (contrasts) to narrow down the list of possible candidate genes.

Methods
=======

Fish maintenance and embryo collection
--------------------------------------

The following zebrafish lines were used in this study: wild-type (WT) AB and *smarca4^a50/+^* (*yng*), which was originally generated from the AB line \[[@r21],[@r22]\]. The WT parents were the genotyped WT siblings of the *smarca4^a50/+^*, and are isogenic other than the *smarca4^a50^* allele. The adult breeders were maintained according to standard procedures \[[@r28]\]. Embryo collection, staging, and incubation were performed according to standard procedures. The embryos used for an individual experiment were collected from the same parents and spawned within a 15 min interval. All protocols were approved by the Purdue Animal Care and Use Committee.

Microdissection of zebrafish retina and RPE--attached retinas
-------------------------------------------------------------

Microdissection of retinas and RPE-attached retinas from WT and *smarca4 ^a50/\ a50^* embryos at 52 h post-fertilization (hpf) was conducted as described \[[@r9]\]. WT retinas (WR52) and WT RPE-attached retinas (WRR52) were originally collected and reported in \[[@r8]\], *smarca4/yng* retinas (YR52) were originally collected and reported in \[[@r23]\], and *smarca4* RPE-attached retinas (YRR52) were collected in this study. Three biologic replicates were collected for each condition, and the number of tissues in each replicate is shown in [Table 1](#t1){ref-type="table"}.

###### The eye tissue samples used in the microarray analysis.

  **Parameters measured in each replicate (3 replicates per group)**   **WT retina (WR52)**    **WT retina+RPE (WRR52)**   ***smarca4* retina (YR52)**   ***smarca4* retina+RPE (YRR52)**
  -------------------------------------------------------------------- ----------------------- --------------------------- ----------------------------- ----------------------------------
  Number of tissue per replicate                                       10, 10, 10              10, 10, 10                  10, 9, 10                     6, 6, 6
  RNA yield from extraction (3 replicates)/ ng                         170.1, 179.93, 153.22   218.69, 179.83, 266.87      138.6, 164.3, 204.37          112.18, 118.4, 142.1
  Input RNA amount for Affymetrix/ ng                                  33, 33, 33              33, 33, 33                  33, 33, 33                    24, 24, 24

Four types of eye tissue samples were used in this study, including WT retina (WR52), WT retina+RPE (WRR52), *smarca4* retina (YR52) and *smarca4* retina+RPE (YRR52). Three independent biologic replicates were collected and the number of samples in each replicate is listed. The yield of the total RNAs extracted from these samples and the input RNA amount used for each Affymetrix GeneChip experiment are listed in the Table as well. These parameters were also used in the estimation of RNA expression values as described in Methods.

Total RNA extraction and microarray analysis
--------------------------------------------

Total RNA extraction was performed with an optimized procedure that combined TRIzol (Life Technologies, Grand Island, NY) and column-based purification (Qiagen, Valencia, CA) \[[@r8],[@r29]\]. The yield ([Table 1](#t1){ref-type="table"}) and the quality of the purified total RNAs were evaluated with NanoDrop spectrophotometry (Thermo Scientific, Wilmington, DE) and Bioanalyzer electrophoresis (Agilent Technologies, Santa Clara, CA), respectively. Total RNAs were amplified and labeled using a two-cycle target-labeling protocol (Affymetrix, Santa Clara, CA), and hybridized to GeneChip Zebrafish Whole Genome arrays (Affymetrix). The input RNA amounts are specified in [Table 1](#t1){ref-type="table"}. Hybridization, washing, and scanning were performed according to the manufacturer's standard procedure.

Histology
---------

Histological analysis on 1 μm plastic sections was conducted as previously described \[[@r8]\] and imaged with a SPOT-RT3 color slider camera (Diagnostic Instruments, Sterling Heights, MI) mounted on a BX51 fluorescence compound microscope (Olympus, Center Valley, PA). To analyze the ultrastructural changes in the RPE, transmission electron microscopy (TEM) was used. The samples were fixed and processed as previously described \[[@r30]\]. Ultrathin sections (100 nm) through the optic nerve region were collected for TEM analysis with a Philips CM-10 transmission electron microscope (FEI Company, Hillsboro, OR). The resulting images were merged in Adobe Photoshop CS6 (Adobe, San Jose, CA).

In situ hybridization
---------------------

In situ hybridization was conducted as described \[[@r24]\]. The following riboprobes were used in this study: dopachrome tautomerase (*dct*; GenBank accession number: [NM_131555](http://www.ncbi.nlm.nih.gov/nuccore/NM_131555)) and retinal pigment epithelium-specific protein 65a (*rpe65a*; [NM_200751](http://www.ncbi.nlm.nih.gov/nuccore/NM_200751)). To prepare the probes for these genes, a fragment of each gene was amplified from a cDNA library prepared as described \[[@r29]\]. The primer sequences are as follows: dct-1F: 5′-ACT TCT TCG TCT GGC AGC AT-3′, dct-1R: 5′-CGG CTT ATC ATA TCC CTC CA-3′, rpe65--1F: 5′- GCT TCG AGT CGG ATG AAG AG-3′ and rpe65--1R: 5′-CAG GGA CGA AAT GGT TGA GT-3′. The resulting PCR fragment was cloned into the pGEM-T easy vector (Promega, Madison, WI) for propagation. The riboprobes were synthesized according to standard procedures \[[@r31]\].

Morphometric measurements and general statistical analysis
----------------------------------------------------------

Melanosome and RPE parameters were measured and extracted from the images with i-Solution 10.1 (IMT i-Solution, Burlington, Canada). The morphology of the melanosomes was measured by area and roundness. The latter parameter is defined as 4A/f2π (A = area, f -- max Feret diameter (the longest diameter along the region-of-interest boundary). Thus, 1 = round, 0 = elongated). Standard error propagation was used to combine the measurement errors of the variables. All standard descriptive statistics and data analyses were performed in the [R](http://www.r-project.org) statistical environment version 2.15.2. Melanosome numbers, area and roundness, as well as RPE area were analyzed with standard ANOVA. The melanosomes along the apical/basal axis was demarcated by the center of the RPE nuclei and their number counted. The resulting data were analyzed with logistic regression. An alpha level of 0.05 was used for all general statistical tests.

Microarray data analysis
------------------------

The analysis conducted in this study used the WR52, WRR52, YR52, and YRR52 data as described, as well as the whole embryo data obtained from WT (WA52) and *smarca4* (YA52) previously collected \[[@r23]\]. The microarray data were deposited at the Gene Expression Omnibus ([GEO](http://www.ncbi.nlm.nih.gov/projects/geo/)) under the accession number (GSE50241).

Probe-level analysis and retinal pigment epithelium expression value estimation
-------------------------------------------------------------------------------

The probe-level data of these sample groups were background-adjusted, normalized, and summarized with a robust multiarray average (RMA) algorithm \[[@r32]\] implemented in the *affy* library of the Bionconductor \[[@r33]\] in [R](http://www.r-project.org) statistical environment version 2.15.2, using default parameters. RPE expression values were estimated from the comparison between the retinal samples and the RPE-attached retinal samples of the same genotype based on a method we previously developed \[[@r8]\]. First, the RMA-normalized expression values in RPE-attached retinal sample were adjusted according to the yield and number of tissues with the following equations:

A. WRR52

adjExprWRR52~ij~=ExprWRR52~ij~ x (mean(yieldWRR52~j~/tissueNoWRR52~j~)/mean(yieldWR52~j~/tissueNoWR52~j~))

B. WR52

ExprWR52~ij~ (i.e., no adjustment)

C. YRR52

adjExprYRR52~ij~=ExprYRR52~ij~ x (mean(yieldYRR52~j~/tissueNoYRR52~j~)/mean(yieldYR52~j~/tissueNoYR52~j~))

D. YR52

ExprYR52~ij~ (i.e., no adjustment)

where Expr is the expression value of a gene i in replicate j, adjExpr is the adjusted expression value of a gene i in replicate j, yield is the total RNA yield of replicate j, and tissueNo is the number of tissue used in replicate j; i=1,...,n; j=1,2,3.

Then, the RPE expression in WT and *smarca4* was estimated as follows:

RPEWT52=adjExprWRR52~ij~ -- ExprWR52~ij~

RPEyng52=adjExprYRR52~ij~ -- ExprYR52~ij~

Factorial analysis and gene selection
-------------------------------------

A factorial analysis \[[@r23]\] was conducted using the adjusted RPE expression values, as well as the retinal and whole-embryo values. The overall design is a 3×2 model ([Figure 1A](#f1){ref-type="fig"}) that determines the effect of tissue type (T) and mutation (M) on the expression level. The corresponding levels of each factor are listed below:

![Schematic diagrams of the factorial design and gene selection approach. **A**: A 3x2 factorial design used in the expression data analysis. There are two main factors in the model: Tissue (T) and Mutation (M). The tissue factor T has three levels: whole embryo, retina and RPE, whereas the mutation factor M has two levels: WT and *smarca4*. For each gene *y*, its expression value in different experimental conditions was explained by the corresponding equations. The presence of a factor was represented by a coefficient in the equation. Using the whole family of equations, the statistical modeling explained the contribution of the individual coefficients in the final expression level. **B**: The gene selection was based on statistical testing with the specific combination of the coefficients in the fitted model for a biological question, i.e. contrast. In this study, we further combined several contrasts to develop rules for selecting three groups of genes: i) SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 (*smarca4*)-regulated RPE genes (black circle; [Table 3](#t3){ref-type="table"} and Appendix 5), ii) *smarca4*-regulated retinal genes (dark blue circle; [Table 4](#t4){ref-type="table"} and Appendix 7), and iii) *smarca4*-regulated RPE genes that are not differentially expressed in the retina (black circle outside the light blue circle; [Table 5](#t5){ref-type="table"} and Appendix 9). We theorized that genes that were only differentially expressed in RPE but not retina would constitute two types of genes that may explain the *smarca4* RPE and retinal phenotype. The first type contains signal transducers inside RPE that their dysfunction would cause the *smarca4* RPE defects, while the second type contains signaling molecules that were secreted by RPE that might cause the *smarca4* retinal phenotype. To select this third group of genes, we first obtained a very inclusive group of retinal gene that was differentially expressed in retina (light blue circle). Then, we excluded these genes from the *smarca4-*regulated RPE genes (black circle). Finally, 39 differentially-expressed RPE genes were selected.](mv-v20-56-f1){#f1}

Mutation (M) -- two levels: WT and smarca4

Tissue (T) -- three levels: whole embryo, retina, and RPE

For any gene *g*, its expression (*y~g~*) in the six experimental conditions in [Figure 1A](#f1){ref-type="fig"} was modeled with the following equations:

WT~embryo~: y~g~ = μ (Eq. 2.1)

WT~retina~: y~g~ = μ + T~R~ (Eq. 2.2)

WT~RPE~: y~g~ = μ + T~RPE~ (Eq. 2.3)

*smarca4*~embryo~: y~g~ = μ + M (Eq. 2.4)

*smarca4*~retina~: y~g~ = μ + M + T~R~ + M\*T~R~ (Eq. 2.5)

*smarca4*~RPE~: y~g~ = μ + M + T~RPE~ + M\*T~RPE~ (Eq. 2.6)

The candidate genes for a specific biologic question were selected by building contrast with the coefficients in Equations 2. In other words, two conditions were statistically compared to identify differentially expressed genes among the conditions (see \[[@r23]\] for further discussion and examples). Depending on whether the two-way interaction term in the Equations 2 was significant or not, the resulting contrasts had to be built differently. In other words, there were first-order (two-way interaction term is not significant) and second-order models (two-way interaction term is significant). Multiple hypothesis testing was corrected by calculating the false discovery rate (FDR). A gene was inferred as differentially expressed when the contrast in consideration had a *q* value less than 0.001 unless specified otherwise. By combining multiple contrasts, specific rules were built to select 1) *smarca4*-regulated RPE genes, 2) *smarca4*-regulated retinal genes, and 3) *smarca4*-regulated RPE genes that are not differentially expressed in the retina (see the corresponding Result sections for the list of contrasts used). A schematic diagram that shows the relationship between these selections and the resulting candidate genes is shown in [Figure 1B](#f1){ref-type="fig"}. General gene annotations were adopted from an annotation file from Affymetrix (Zebrafish annotation release 30). The selected RPE genes were also analyzed with the Database for Annotation, Visualization, and Integrated Discovery ([DAVID](http://david.abcc.ncifcrf.gov/)) v6.7 \[[@r34],[@r35]\] using default parameters. Further grouping was aided by the fold change of a comparison. If an estimated expression value was less than zero, indicating the gene was not expressed in the condition, the value was artificially set as one.

Results
=======

Differentiation of *smarca4* RPE is abnormal
--------------------------------------------

One distinctive feature of *smarca4* mutant was the lower level of pigmentation in pigment cells, including the RPE. The *smarca4* RPE cells developed pigmentation at around 24 hpf, a stage when the WT RPE cells began to differentiate and form pigment. However, the pigmentation level was always less intense in *smarca4*. By 52 hpf, the whole eye was covered with RPE and appeared dark in the WT ([Figure 2A,E](#f2){ref-type="fig"}), while the *smarca4* RPE cells were noticeably less pigmented, particularly on the ventral side ([Figure 2B,F](#f2){ref-type="fig"}, red arrow). At this stage, there is differentiation of several retinal cell types in the WT eye, and retinal lamination is present \[[@r30],[@r36],[@r37]\]. In contrast, the *smarca4* retina at 52 hpf was dystrophic and would gradually decrease \[[@r21]-[@r23]\] ([Figure 2F](#f2){ref-type="fig"}). As a result, the *smarca4* eyes were noticeably different from the WT eyes at 72 hpf ([Figure 2C,D,G,H](#f2){ref-type="fig"}). Although the *smarca4* RPE was more pigmented at this stage, the RPE cells were still abnormal with holes detected in the RPE layer ([Figure 2G,H](#f2){ref-type="fig"}, red arrow).

![*Smarca4* RPE development is abnormal. **A**--**D**: Whole-mount wild type (WT) and SWI/SNF-related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 (*smarca4*) eyes at 52 and 72 h post-fertilization (hpf) are shown. The lateral view is shown. Anterior is to the left, and dorsal is up. The red arrow in **B** indicates a ventral region of *smarca4* where the retinal pigment epithelium (RPE) pigmentation level was lower than the other regions. **E--H**: Transverse histological sections of the WT and *smarca4* eyes at 52 and 72 hpf are shown. One distinctive hallmark of *smarca4* is the disruption of their retinal lamination. In addition, the *smarca4* RPE appears paler (**B** and **E**, red arrow) and dysmorphic (**H**, red arrow) compared with the WT. In these sections, lateral is to the left, and dorsal is up. The RPE differentiation problem was further illustrated with in situ hybridization with dct (**I**--**L**) and *rpe65a* (**M**--**P**) at 52 hpf. The expression of *dct*was comparable between WT and *smarca4* RPE, suggesting that the RPE cells in *smarca4* were still committed to the pigment cell lineage. Nonetheless, the differentiation of *smarca4* was abnormal. This was demonstrated by the slightly irregular staining of *dct* and very irregular staining of *rpe65a*, a differentiation marker. In both cases, the dorsal-tilted view (**I**, **J**, **M**, and **N**) and the ventral view (**K**, **L**, **O**, and **P**) are shown, and the anterior side is to the left. Scale bars=50 μm.](mv-v20-56-f2){#f2}

To analyze the differentiation problem of the *smarca4* RPE, we first conducted an in situ hybridization analysis at 52 hpf with *dct* and *rpe65a*, a pigment cell and an RPE-specific marker, respectively. Dct is a key enzyme in the melanogenesis pathway melanin synthesis \[[@r38]\], which gives the pigment cells the distinctive black color. The *dct* signal generally covered the eye surface of the WT ([Figure 2I,K](#f2){ref-type="fig"}) and *smarca4* embryos ([Figure 2J,L](#f2){ref-type="fig"}), suggesting that the *smarca4* RPE cells were still committed to the pigment cell lineage. However, the *smarca4* staining was irregular, which indicates abnormal RPE differentiation. Indeed, this was supported by the staining of *rpe65a,* an RPE-specific enzyme that mediates a critical step of isomerization of all-trans-retinol to 11-cis-retinal in the visual cycle \[[@r39]\]. In WT embryos, the staining was intense in the anterior region of the eye and highlighted the RPE cell shape clearly ([Figure 2M,O](#f2){ref-type="fig"}), while in the *smarca4* embryos, the staining was irregular ([Figure 2N,P](#f2){ref-type="fig"}), and the extent of staining was far less comprehensive than that observed with *dct* expression ([Figure 2J,O](#f2){ref-type="fig"}).

The differentiation defects of the *smarca4* RPE were further analyzed with TEM at 52 hpf. The *smarca4* RPE had fewer melanosomes compared with WT ([Figure 3A](#f3){ref-type="fig"}), which is consistent with the pigmentation defects observed in the semithin sections ([Figure 2F,H](#f2){ref-type="fig"}). In addition, there appeared to be fewer melanosomes on the basal side of the cell (red arrow). To quantify these changes, three independent transverse sections of WT and *smarca4* eyes were collected and several RPE attributes measured. First, the number of melanosomes per RPE cell area was analyzed ([Figure 3B](#f3){ref-type="fig"} and [Table 2](#t2){ref-type="table"}). The RPE on the dorsal and ventral sides of the optic nerve (ON) was analyzed separately. A two-way ANOVA indicated that there were fewer melanosomes/RPE cell area in *smarca4* (p value=1.43e-4) and in the RPE ventral to the ON in both genotypes (p value=4.91e-4; see detailed descriptions of the ANOVA output in Appendix 1). In addition, the total RPE area in the *smarca4* embryos was not smaller than that in the WT embryos (WT: 1176.36±58.24 μm^−2^; *smarca4*:1078.35±133.05 μm^−2^; Mann--Whitney test; p value=0.7). Together, these results suggest that there was a general decrease in the melanosome number at this stage. Second, the distribution of the melanosomes in the RPE was evaluated by calculating the apical/basal ratio, using the center of the flattened nuclei to demarcate the apical and basal sides of the RPE cells ([Figure 3C](#f3){ref-type="fig"} and [Table 2](#t2){ref-type="table"}). A logistic regression analysis of the counts demonstrates that the melanosomes in the *smarca4* RPE had an apical bias (p value=3.47e-12) and that there was a general apical bias in the ventral RPE compared with the dorsal RPE in both genotypes (p value=6.15e-07; Appendix 2).

![Ultrastructural analysis of *smarca4* RPE with transmission electron microscopy at 52 hpf indicates defects in melanogenesis. **A**: An example retinal pigment epithelium (RPE) cell of wild-type (WT) and *smarca4* is shown*.* The red arrow indicates the basal side of the RPE cell. Scale bar=5 μm. Three whole-eye transverse sections were collected for each genotype and several morphometric measurements of the melanosomes conducted. The results are shown in **B**--**E**. **B**: A strip chart of the number of melanosome per RPE cell area is shown. **C**: A strip chart of the apical/basal melanosome ratio in the RPE is shown. **D**: A boxplot of the melanosome roundness (1: round; 0: elongated). **E**: A boxplot of the melanosome area. The box plot is a graphical representation based on the distribution of the data. The box shows the interquartile range (IQR) and the thick line inside the box shows the median. The dotted lines show the largest or smallest values that fall within 1.5 times the IQR from the closest edge of the box. Values that are outside this range are considered outliers and were plotted as individual circles. In all these plots, the data obtained from the RPE dorsal and ventral to the optic nerve are plotted separately. The corresponding statistical analyses are shown in Appendix 1--Appendix 4, respectively.](mv-v20-56-f3){#f3}

###### Morphometric analyses of melanosomes in WT and *smarca4* RPE.

  **Measurement**                                 **WT dorsal RPE (µ±s)**   **WT ventral RPE (µ±s)**   ***smarca4* dorsal** **RPE (µ±s)**   ***smarca4* ventral** **RPE** **(**$\overset{-}{\mathbf{x}}$**±*s)***   **Figure and Data analysis**
  ----------------------------------------------- ------------------------- -------------------------- ------------------------------------ ----------------------------------------------------------------------- -------------------------------------------------
  Number of melanosomes/ RPE cell area (μm^−2^)   1.92±0.24                 1.36±0.15                  1.27±0.14                            0.80±0.41                                                               [Figure 3B](#f3){ref-type="fig"} and Appendix 1
  Apical/basal ratio                              1.46±0.13                 1.78±0.18                  1.92±0.25                            2.77±1.87                                                               [Figure 3C](#f3){ref-type="fig"} and Appendix 2
  Roundness (1=round, 0=elongated)                0.81±0.16                 0.79±0.18                  0.80±0.17                            0.80±0.16                                                               [Figure 3D](#f3){ref-type="fig"} and Appendix 3
  Area (μm^−2^)                                   0.14±0.09                 0.12±0.09                  0.12±0.10                            0.13±0.09                                                               [Figure 3E](#f3){ref-type="fig"} and Appendix 4

The four measurements that were analyzed are: number of melanosomes/RPE area, apical/basal ratio, roundness and area. The apical/basal ratio was used to evaluate the distribution of melanosomes inside the RPE cells. The center of the flattened nuclei was used to demarcate the apical and basal side of the RPE cell. Then, the position of the melanosome was scored. The roundness is a measure to evaluate the maturity of the individual melanosomes as the mature ones tend to be ellipsoidal in shape while the immature ones are more circular. Furthermore, the size of the individual melanosome was also evaluated by area measurement. The analysis was also independently done on RPE dorsal and ventral to the optic nerve. The numbers presented are in the format of mean±standard deviation (µ±s). The corresponding plots and data analysis outputs are shown in [Figure 3B-D](#f3){ref-type="fig"} and Appendix 1- Appendix 4 respectively. In summary, there was a reduction in the number of melanosome, an apical bias and a small reduction in area in the *smarca4* RPE. These observations suggest that the melanogenesis was impaired in the *smarca4* RPE.

Melanosomes mature through distinctive phases from the circular immature type to the ellipsoidal mature type \[[@r40]\]. To assess the maturity of the melanosomes, their roundness (1: circular; 0: elongated; [Figure 3D](#f3){ref-type="fig"} and [Table 2](#t2){ref-type="table"}) and area ([Figure 3E](#f3){ref-type="fig"} and [Table 2](#t2){ref-type="table"}) were separately evaluated with two-way ANOVA. The analysis shows that the roundness of the melanosomes was not affected by genotype (p value=0.67; Appendix 3). There was also no difference in melanosome roundness between the dorsal and ventral RPE (p value=0.07). These observations suggest that the melanosome maturity, as assessed by shape, was similar between the *smarca4* and WT genotypes. However, there was a small but statistically significant decrease in the melanosome area in *smarca4* RPE (p value=1.96e-7), and in the ventral RPE for both genotypes (p value=2.37e-6; Appendix 4). In addition, the decrease in melanosome size in *smarca4* RPE was less drastic in the ventral side (p value=0.0066). Together, these histological data suggest that *smarca4* RPE cells were formed, but the differentiation was abnormal at 52 hpf. This observation is consistent with the overall impairment of melanogenesis observed in the *smarca4* mutants.

Microarray analysis of *smarca4* retina and RPE
-----------------------------------------------

The differentiation defects in the smarca4 RPE suggest that the absence of *smarca4* disrupted the regulation and expression of genes that were key to normal RPE differentiation. Furthermore, terminal differentiation was also impaired in the *smarca4* retina, resulting in abnormal retinal lamination ([Figure 2F](#f2){ref-type="fig"}) \[[@r21]-[@r23]\]. Since the RPE and the retina interact closely during development, we were interested in elucidating whether the retinal phenotype might be secondary to disruption of normal signals between the developing RPE and retina. To this end, we extended a factorial analysis framework \[[@r23]\] that was previously used to study *smarca4* retinal differentiation. An overview is described (also see the Methods section for the details of the statistical framework).

First, the RPE expression values were estimated by comparing the retinas and the RPE-attached retinas \[[@r8]\]. Then, a 3×2 factorial design ([Figure 1A](#f1){ref-type="fig"}) was used to analyze the expression values of three kinds of tissue (T: whole embryo, retina, and RPE) in two mutation backgrounds (M: WT and *smarca4*). The expression value of a gene in the individual conditions (*y~g~*) was deconstructed into coefficients that represented the contribution to the expression level by the presence of that factor ([Figure 1A](#f1){ref-type="fig"}, equations under the condition name). Using these coefficients, contrasts were built to identify candidate genes that fulfilled specific criteria. The false discovery rate (FDR) *q* value cutoff for a contrast was 0.001. Several contrasts were ultimately combined to select genes that were regulated by *smarca4* in the retina and the RPE ([Figure 1B](#f1){ref-type="fig"}) and will be discussed below. In addition, a fold-change between *smarca4* and WT was calculated to aid ranking of the resulting gene list.

Smarca4*-regulated RPE genes*
-----------------------------

The contrasts selected genes that were differentially expressed in the WT or *smarca4* RPE and at the same time were regulated by *smarca4*, either directly or indirectly ([Figure 1B](#f1){ref-type="fig"}, black circle; [Table 3](#t3){ref-type="table"}). A total of 591 genes were selected (Appendix 5). Among them, 432 and 162 genes were under- and overexpressed in the *smarca4* RPE when compared with the WT RPE, respectively. Seven genes had negative RPE expression value in WT and *smarca4* and were not biologically meaningful. DAVID analysis of these genes revealed two functional annotation groups that were highly enriched (Appendix 6; Benjamini-adjusted p value=2.7e-2). These groups include two gene ontology (GO) terms for cellular components: non-membrane-bounded organelle (32 genes/6.1% of total annotated genes) and intracellular non-membrane-bounded organelle (32 genes/6.1% of total annotated genes). These terms refer to organized structures that are not bound by a lipid bilayer membrane including the cytoskeleton, suggesting that the cytoskeletal dynamics of the *smarca4* RPE were impaired. Further selection of these RPE candidate genes is described in the third subsection.

###### Contrasts for selecting Smarca4-regulated RPE genes.

  Question                                                                  Contrast                                                                   Number of genes   Appendix
  ------------------------------------------------------------------------- -------------------------------------------------------------------------- ----------------- ----------
  1\. Gene differentially expressed in WT RPE                               H~0~: T~RPE~=0                                                             6306              \-
  2. Gene differentially expressed in *smarca4* RPE                         H~0~: T~RPE~ + M\*T~RPE~=0                                                 4851              \-
  3. Gene differentially expressed in WT OR *smarca4* RPE                   H~0~: T~RPE~=0 OR H~0~: T~RPE~ + M\*T~RPE~=0                               8536              \-
  4. Smarca4-regulated RPE genes that are differentially expressed in RPE   H~0~: M + M\*T~RPE~=0 AND (H~0~: T~RPE~=0 OR H~0~: T~RPE~ + M\*T~RPE~=0)   591               5

These contrasts are listed in the sequential order of building up the final conclusion (Question 4). Each row lists the question, the corresponding contrast that was tested, and the number of genes less than the q-value cutoff (\< 0.001). The final 591 selected genes that were selected in Question 4 are listed in Appendix 5. This group of genes is also illustrated in the black circle in [Figure 1](#f1){ref-type="fig"}. These candidate genes are both differentially expressed in the RPE compared with the whole embryo and at the same time regulated by *Smarca4* in the RPE.

Smarca4*-regulated retinal genes*
---------------------------------

The contrasts selected genes that were differentially expressed in the WT or *smarca4* retina and at the same time regulated either directly or indirectly by *smarca4* ([Figure 1B](#f1){ref-type="fig"}, dark blue circle; [Table 4](#t4){ref-type="table"}). A total of 412 genes were selected (Appendix 7). Among them, 252 and 160 genes were under- and overexpressed in the *smarca4* RPE when compared with the WT RPE, respectively. Many gene candidates were previously identified from a microarray analysis of the *smarca4* retinas \[[@r23]\] and were validated in subsequent follow-up experiments \[[@r24],[@r25],[@r27]\]. Furthermore, we identified the *smarca4* gene itself as under-expressed in the *smarca4* retina, which validated the array experiment and our statistical selection. This is because the null-mutation was expected to result in nonsense-mediated decay of the mRNA and reduce its gene expression. DAVID analysis of these genes revealed several similar functional annotation groups that were enriched (Appendix 8; Benjamini-adjusted p value \<0.05; see the table for the gene count and percentage of total annotated genes). For example, eight terms are related to cytoskeletal dynamics, nine terms are related to the cell cycle, and four terms are related to neuron/eye morphogenesis.

###### Contrasts for selecting Smarca4-regulated retinal genes.

  Question                                                                        Contrast                                                           Number of genes   Appendix
  ------------------------------------------------------------------------------- ------------------------------------------------------------------ ----------------- ----------
  1. Gene differentially expressed in WT retina                                   H~0~: T~R~=0                                                       4830              \-
  2. Gene differentially expressed in *smarca4* retina                            H~0~: T~R~ + M\*T~R~=0                                             799               \-
  3. Gene differentially expressed in WT OR *smarca4* retina                      H~0~: T~R~=0 OR H~0~: T~R~ + M\*T~R~=0                             4842              \-
  4.Smarca4-regulated retinal genes that are differentially expressed in retina   H~0~: M + M\*T~R~=0 AND (H~0~: T~R~=0 OR H~0~: T~R~ + M\*T~R~=0)   412               7

These contrasts are listed in the sequential order of building up the final conclusion (Question 4). Each row lists the question, the corresponding contrast that was tested, and the number of genes less than the q-value cutoff (\< 0.001). The final 412 selected genes that were selected in Question 4 are listed in Appendix 7. This group of genes is also illustrated in the dark blue circle in [Figure 1](#f1){ref-type="fig"}. These genes are both differentially expressed in the retina compared with the whole embryo and at the same time regulated by Smarca4 in the retina.

Comparing the final list in groups (i) and (ii) showed that 51 genes were commonly expressed in both groups ([Figure 1B](#f1){ref-type="fig"}, the white region between the black and blue circles), while 540 and 361 genes were uniquely expressed in (i) and (ii), respectively. Thus, a total of 952 genes were identified. Among them, 293 (30.78%) had no annotation.

Smarca4*-regulated RPE genes that were not differentially expressed in the retina*
----------------------------------------------------------------------------------

We theorized that paracrine signaling genes would likely be differentially expressed in one of the two interacting cell-types (i.e., the retina and the RPE), either as secreted ligands or the intracellular signal transducers. To identify these candidate genes in *smarca4* RPE, additional selection criteria were imposed on the group (*i*; [Table 5](#t5){ref-type="table"}). In particular, these genes should not be differentially expressed in WT or *smarca4* retinas. In other words, we selected for genes with RPE-specific differential expression. Specific contrasts were first built to identify retinal-specific genes in WT and *smarca4* retinas with a relatively inclusive cutoff (*q* value \<0.05; [Figure 1B](#f1){ref-type="fig"}, light blue circle). Then, these genes were removed from the candidate gene group (*i*) to select for the genes that were regulated by *smarca4* in the RPE but were not differentially expressed in the retina.

###### Contrasts for selecting Smarca4-regulated RPE genes that are not differentially expressed in the retina.

  Question                                                                                                                                                                                                                                                       Contrast                                                                                                                                                                                             Number of genes   Appendix
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------- ----------
  1. Smarca4-regulated RPE genes that are differentially expressed in RPE                                                                                                                                                                                        H~0~: M + M\*T~RPE~=0 AND (H~0~: T~RPE~=0 OR H~0~: T~RPE~ + M\*T~RPE~=0)                                                                                                                             591               5
  2\. Smarca4-regulated RPE genes that are i) differentially expressed in RPE, and ii) not differentially expressed in WT retina\*, and iii) not differentially expressed in *smarca4* retina\* \* those genes with a contrast q-value \>0.05 will be included   i\) H~0~: M + M\*T~RPE~=0 AND H~0~: T~RPE~=0 OR H~0~: T~RPE~ + M\*T~RPE~=0 NOT ii) H~0~: T~R~=0\* NOT iii) H~0~: T~R~ + M\*T~R~=0\* \* those genes with a contrast q-value \>0.05 will be included   39                9

These contrasts are listed in the sequential order of building up the final conclusion. Each row lists the question, the corresponding contrast that was tested, and the number of genes less than the q-value cutoff (\< 0.001; except for \*, in which those genes that have a q-value \> 0.05 are included. In other words, these genes are also not differentially expressed in the retina. Also see [Figure 1](#f1){ref-type="fig"}). The final 39 selected genes are listed in Appendix 7. In summary, this group of genes is regulated by *Smarca4* and not differentially expressed in the retina. These genes are inside the black circle and outside the light-blue circle in [Figure 1](#f1){ref-type="fig"}.

A total of 39 genes were selected based on these criteria (Appendix 9). Among them, 31 were under-expressed in the *smarca4* RPE, while the remaining eight were overexpressed. Based on their annotations and previous investigations in humans \[[@r41]-[@r44]\], mice \[[@r44]-[@r46]\], chicks \[[@r10]\], and zebrafish \[[@r8]\], we found that many of the known genes are expressed in the RPE and potentially play an important role in RPE signaling and physiology (Appendix 9; supporting evidence columns). For example, previous studies had detected expression of 31 out of 39 (79.5%) genes in the RPE. Among these data, the zebrafish data represent carefully selected RPE genes that were consistently expressed in our previous investigation \[[@r8]\] (Appendix 9). Even if the zebrafish data are excluded from this calculation, studies in the other systems still support the expression of 22 out of 39 (56.4%) genes in RPE. Therefore, these selected *Smarca4*-regulated RPE genes represent a group of highly validated RPE-specific genes. DAVID analysis of these genes also revealed two enriched functional annotation groups with more than two genes in each group (Appendix 10; p value\<0.05). These functional annotation groups include the focal adhesion pathway (four genes; 12.5% of total annotated genes) and the melanogenesis pathway (three genes; 9.375% of total annotated genes).

Discussion
==========

This study established an approach for analyzing differential gene expression between the RPE and retina in zebrafish, as well as identifying a group of candidate genes that may underlie the developmental defects observed in the *smarca4* RPE and the retina. Although the analytical emphasis was on the RPE, the same approach could be used to analyze the retina and its secreted signals. This approach focuses on tissue-level expression, and thus may complement cell-level approaches, including expression profiling of FACS-purified cells from the RPE-specific reporter lines. An alternative approach to RPE cell purification for expression study is by density gradient centrifugation followed by FACS using pigment granule density as a sorting criterion \[[@r12]\]. This alternative approach may alleviate the need to use RPE-specific reporter lines for RPE expression profiling, which may not be readily applicable to all experimental conditions. However, FACS requires enzymatic dissociation of individual cells, which may affect cell physiology, as well as gene expression. Furthermore, the preparation time from embryos to sorted cells can take several hours. As a result, using FACS for RPE expression analysis may not reveal the desired expression profile at a specific stage. We believe that our approach, which measures at a precise developmental stage, can complement the FACS approach and that together the approaches will facilitate RPE developmental analysis.

Further literature searches revealed potential candidates from the 39 genes in group (iii) that could affect RPE/melanosome differentiation, cytoskeletal dynamics, and cell-cell signaling ([Table 6](#t6){ref-type="table"}). These observations are also supported by the functional annotation enrichment revealed by the DAVID analysis (Appendix 10). These genes belong to the under-expression category (i.e., *smarca4*/WT RPE expression fold change \<1). The first category contains 12 genes (*si:ch211--87l2.1, fancl, magi2, map2k1, myl12.2, nav2b, pacrg, pdcl3, ppp1r12a, sec23ip, smarca2, and tubb5)* that may provide insight into the abnormal RPE development in the *smarca4* mutant, particularly regarding two interdependent processes: cytoskeletal dynamics and melanogenesis \[[@r47]\]. For example, *si:ch211--87l2.1* is a novel gene that is predicted to be a Rab GTPase activator by sequence homology ([ZDB-GENE-030131--4497](http://zfin.org/action/marker/view/ZDB-GENE-030131-4497); this is the ID used in the zebrafish community website for the gene). Rab GTPases are small GTPases that regulate membrane trafficking. Functional impairment in specific Rab proteins including Rab32/38 and Rab27A causes pigmentation disorders \[[@r48]\]. Rab27A forms a complex with myosin VIIa and another interacting protein MyRIP, and this complex mediates local trafficking of retinal melanosomes to actin cytoskeleton \[[@r49]\]. Mutations in myosin VIIa in patients with Usher syndrome cause abnormal melanosome distribution in the RPE \[[@r50]\], a phenotype that mimics that seen in the *smarca4* RPE. Together, these observations suggest that the abnormal expression of *si:ch211--87l2.1* might partially underlie the abnormal melanogenesis defects observed in the *smarca4* RPE. Another gene, *fancl*, is an enzyme implicated in Fanconi anemia \[[@r51]\]. One of the clinical symptoms of Fanconi anemia is pigmentation abnormalities \[[@r52]\], which suggests that *fancl* may play also a role in melanogenesis. *Map2k1* is related to melanosome transport ([Entrez Gene ID:5604](http://www.ncbi.nlm.nih.gov/gene/5604)) and pigmentation disorders \[[@r52]\]. *Myl12.2* was identified in a proteomic study of human RPE blebs, abnormal cell membrane structures that may contribute to drusen formation in age-related macular degeneration \[[@r41]\]. *Nav2b* is involved in actin dynamics \[[@r53]\] and plays a role in cell migration and the outgrowth of cellular processes, including axons \[[@r54]\]. *Pacrg* forms a molecular chaperone complex called chaperonin containing TCP1 complex (CCT) \[[@r55]\]. One of its components, CCT4, has been shown to bind to melanosome in a proteomic characterizations \[[@r56]\]. CCT is also involved in the biogenesis of many cytoskeletal proteins, including actins and tubulins. Another selected gene in the category, *Pdcl3/ PhLP2A*, physically interacts with CCT and modulates its folding activity \[[@r57]\]. Thus, the defects in melanogenesis and cytoskeletal dynamics in the *smarca4* RPE might be secondary to dysregulated CCT activity. Furthermore, *ppp1r12a* (also known as MYPT1 (Entrez Gene ID: 4659)) is a myosin phosphatase. *Smarca2,* another family member of *smarca4,* interacts with the intermediate filament \[[@r58]\]( [ENSG00000080503](http://www.proteinatlas.org/ENSG00000080503)). *Magi2* has been shown to be a component of tight junction \[[@r59]\] and is regulated by the planar cell polarity pathway in glomerular podocytes \[[@r60]\]. Together, the under-expression of these genes in *smarca4* RPE might contribute to defects in cytoskeleton and cell-cell adhesion. Consistent with a defect in cell-cell adhesion, we noticed in our experiments that the *smarca4* RPE cells did not adhere to each other well during retinal dissection.

###### Selected under-expressed Smarca4-regulated RPE genes that were not differentially expressed in the retina revealed potential biologic insights on the morphological defects.

  **Biological comparison**                       **Potentially relevant biologic functions**                                                                                                                                                               
  ----------------------------------------------- ----------------------------------------------------------------------------------------------------------- ------------------------------------ -------------------------------------------------------- -----------
  ***Smarca4/*WT RPE expression fold change\***   **Cytoskeletal dynamics/ melanosomes formation/ membrane trafficking**                                      **Secreted/extracellular signals**   **Intracellular signal transducers**                     **Other**
  **\<1 (under-expressed in *smarca4* RPE)**      *si:ch211--87l2.1, fancl, magi2, map2k1, myl12.2, nav2b, pacrg, pdcl3, ppp1r12a, sec23ip, smarca2, tubb5*   *adam9, bmp8a, gdnf*                 *ghdc, guk1a, gsk3b, map2k1, ppp1r12a, spdya, tcf7l1a*   *phyh*

A literature search was conducted on the 39 Smarca4-regulated RPE genes to gain insights into their potential roles in *smarca4* RPE/retinal development. Several genes that were under-expressed in the *smarca4* RPE have related functional roles in cytoskeletal dynamics, melanogenesis, paracrine and/or intracellular signaling; and the relevance of these functions is elaborated in the discussion section. Some of these genes are listed under different categories as they have multiple functional roles.

Our statistical design also allowed for the detection of RPE-secreted signals, including *adam9, gdnf*, and *bmp8a,* which may play a role in retinal development and degeneration ([Table 6](#t6){ref-type="table"}). *Adam9* is a protein secreted by the RPE located within the inter-photoreceptor matrix \[[@r61]\]. *Adam9* is believed to mediate photoreceptor outer segment (POS) attachment to the RPE. *ADAM9* mutations in humans, mice, and dogs cause cone-rod dystrophy \[[@r44],[@r62]\]. In these cases, the apical processes of the RPE are disorganized, and the adhesion between RPE and POS is compromised. We also noticed that the *smarca4* RPE did not tightly adhere to the retina. *Gdnf* is secreted by cultured RPE cells, and its presence in the culture medium enhances the survival of dopaminergic neurons \[[@r15]\]. *Gdnf* also regulates proper photoreceptor development in chickens \[[@r14],[@r16]\]. *Bmp8a*, a member of the Bmp signal transduction pathway, protects mouse osteoblasts from glucocorticoid-induced apoptosis \[[@r63]\]; however, the role of *Bmp8a* in RPE and retinal development has not been fully characterized. The attenuation of secreted signals in the *smarca4* RPE might affect the surrounding tissues, including the retina and the RPE. Furthermore, this observation suggests that other tissues, including paraocular tissues, may play a signaling role in the developmental defects of the *smarca4* retina and RPE, as the *smarca4* mutation affects multiple organ systems.

The third gene category among these 39 selected genes in [Table 6](#t6){ref-type="table"} includes intracellular signal transducers that were specifically affected in the RPE and not differentially expressed in the retina. A total of seven genes are in this category, including *ghdc, guk1a, gsk3b, map2k1, ppp1r12a, spdya*, and *tcf7l1a.* These transducers are involved in different cellular processes, and two, *gsk3b* and *tcf7l1a*, are related to Wnt signal transduction. Gsk3β modulates cytoskeletal dynamics \[[@r64]\] and cell-cell adhesion \[[@r65]\] in the RPE, and in turn helps to establish the epithelial phenotype. Tcf7l1a/Tcf3 is a transcriptional repressor and a target of the Wnt signaling pathway \[[@r66]\]. Under the influence of high levels of Wnt signaling, Tcf7l1a degrades and relieves the transcriptional repression on downstream genes \[[@r67]\]. Therefore, under-expression of these genes in *smarca4* RPE implicates over-activation of the Wnt signaling pathway and overexpression of target genes that would normally be repressed. These events might contribute to the abnormal RPE phenotype.

The *phyh* gene was put in a separate gene category in [Table 6](#t6){ref-type="table"} because the gene's function as a peroxisomal enzyme does not seem to be directly related to the other genes in our study. Nonetheless*,* *phyh* mutation in humans causes Refsum disease, and one of the clinical symptoms of this disease is RP \[[@r68]\]. Thus, a decrease *in* *phyh* in the *smarca4* RPE might also play a role in the *smarca4* phenotype.

The functional annotation analysis of the group (ii) *Smarca4*-regulated retinal genes also revealed enrichment of annotations that are consistent with the *smarca4* retinal phenotype. For example, Link and colleagues showed that there was a cell-cycle withdrawal delay in the *smarca4* retinas \[[@r21]\]. Our analysis identified nine cell-cycle terms enriched in the gene set (Appendix 8). The deregulation of the genes related to these terms in *smarca4* retinas might cause the cell-cycle withdrawal defect. In addition, four and eight terms are related to neuron/retinal differentiation and cytoskeletal dynamics, respectively. This is also consistent with the terminal differentiation defects of the *smarca4* retinas \[[@r21],[@r22]\].

To validate the expression results from this study, quantitative reverse-transcription PCR (qRT-PCR) or northern blot validation should be performed with purified RPE cells rather than estimating the RPE values from dissected eye tissues. This requires generation of RPE reporter lines in WT and *smarca4* for FACS isolation of RPE cells. In Higdon and colleagues' FACS approach, pigment cells were isolated from the whole embryos using pigment granule density \[[@r12]\]. Even though this approach detected an RPE expression signature, it probably requires further optimization before it is applicable to the purification RPE cells from dissected eyes for validation experiments. Laser capture microdissection can be used to obtain some RPE cells but is not feasible for obtaining the whole RPE layer for comparison. Thus, this approach is also not appropriate for validating the findings in this study.

In summary, identifying the *smarca4*-regulated RPE genes with our analysis has highlighted novel and intriguing relationships between RPE cytoskeletal dynamics, membrane trafficking, and intra- and inter-cellular signaling. This new knowledge may ultimately facilitate our understanding of the pathogenesis of related retinal degenerative diseases and development of new therapies.
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